Skip to main content Help with accessibility Skip to main navigation

GLIPTINS (Dipeptidylpeptidase-4 [DPP-4] inhibitors)

CCG Approval Status:

Date Added: 24 - Apr - 2019
Body System:
Green

The Pan Mersey Area Prescribing Committee recommends the prescribing of DPP-4 inhibitors in accordance with NG28-Type 2 diabetes in adults: management.